Assessing Prognosis in Non–Small-Cell Lung Cancer: Avenues to a More Complete Picture?
- 15 August 2004
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 22 (16) , 3209-3211
- https://doi.org/10.1200/jco.2004.05.931
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Upregulation of the Tissue Inhibitor of Metalloproteinase-1 Protein Is Associated With Progression of Human Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2004
- Editorial boardSeminars in Oncology, 2004
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004
- Microarrays and Clinical InvestigationsNew England Journal of Medicine, 2004
- Protein profiles associated with survival in lung adenocarcinomaProceedings of the National Academy of Sciences, 2003
- A molecular signature of metastasis in primary solid tumorsNature Genetics, 2002
- Prognostic Factors in Non-small Cell Lung CancerChest, 2002
- Complex roles of tissue inhibitors of metalloproteinases in cancerOncogene, 2002
- Diversity of gene expression in adenocarcinoma of the lungProceedings of the National Academy of Sciences, 2001